- - - In a study of 460,000+ adults on GLP-1s (mostly with T2D): 13% developed nutritional deficiencies in 6 months 22% within 12 months Vitamin D deficiency was most common (13.6%) 3% experienced muscle loss Patients who saw a dietitian were more likely to have deficiencies identifiednot because dietitians caused harm, but because they actually looked
Efectos de los frmacos con accin sobre el receptor del GLP-1 y enfermedades de la piel Algunos estudios muy preliminares han sugerido que la prdida de peso y la mejora de la inflamacin crnica asociada al tratamiento con ArGLP-1 puede tener un efecto positivo en pacientes con enfermedades dermatolgicas como la psoriasis y la hidrosadenitis supurativa (HS)
Discuss its benefits and risks for your needs
Editorial Advisory Board Member, Harvard Health Publishing Some people who struggle with weight loss have been able to find assistance from several FDA-approved weight-loss medications, such as bupropion plus naltrexone (Contrave), phentermine (Adipex-P), phentermine plus topiramate (Qsymia), and orlistat (Xenical, Alli)
Zepbound is an injectable GLP-1 receptor agonist approved by the FDA in 2023 for weight loss
